TaiwanJ Pharmaceuticals Co (ROCO:6549) Cash-to-Debt : 50.24 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is TaiwanJ Pharmaceuticals Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. TaiwanJ Pharmaceuticals Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 50.24.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, TaiwanJ Pharmaceuticals Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for TaiwanJ Pharmaceuticals Co's Cash-to-Debt or its related term are showing as below:

ROCO:6549' s Cash-to-Debt Range Over the Past 10 Years
Min: 32.66 Med: 1354.58 Max: No Debt
Current: 50.24

During the past 11 years, TaiwanJ Pharmaceuticals Co's highest Cash to Debt Ratio was No Debt. The lowest was 32.66. And the median was 1354.58.

ROCO:6549's Cash-to-Debt is ranked better than
72.56% of 1538 companies
in the Biotechnology industry
Industry Median: 6.485 vs ROCO:6549: 50.24

TaiwanJ Pharmaceuticals Co Cash-to-Debt Historical Data

The historical data trend for TaiwanJ Pharmaceuticals Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

TaiwanJ Pharmaceuticals Co Cash-to-Debt Chart

TaiwanJ Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

44.54

105.00

250.39

32.66

50.24

TaiwanJ Pharmaceuticals Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															250.39	1,486.92	32.66	49.30	50.24

Competitive Comparison of TaiwanJ Pharmaceuticals Co's Cash-to-Debt

For the Biotechnology subindustry, TaiwanJ Pharmaceuticals Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TaiwanJ Pharmaceuticals Co's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiwanJ Pharmaceuticals Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where TaiwanJ Pharmaceuticals Co's Cash-to-Debt falls into.

TaiwanJ Pharmaceuticals Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

TaiwanJ Pharmaceuticals Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	58.829	/	(0.699	+	0.472)
	=	50.24

TaiwanJ Pharmaceuticals Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	58.829	/	(0.699	+	0.472)
	=	50.24

TaiwanJ Pharmaceuticals Co (ROCO:6549) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

TaiwanJ Pharmaceuticals Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of TaiwanJ Pharmaceuticals Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiwanJ Pharmaceuticals Co Ltd (ROCO:6549) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rm. D207, Number 2, Sec.2, ShengYi Road, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei, TWN, 30261

Website

http://www.taiwanj.com

TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Headlines

No Headlines